Let's have permanently quicker drug approvals

16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we ...

Read more →

Dupixent (dupilumab) pre-filled pen now available in Canada, providing convenient self-administration option for people with type 2 inflammatory diseases

17 June 2021 - The pre-filled pen offers an additional administration option for all Dupixent indications in patients aged 12 years ...

Read more →

Sanders 'delighted' DeSantis asked White House to import Canadian prescription drugs

16 June 2021 - Senator Bernie Sanders said in an interview published on Wednesday that he was "delighted" that Florida ...

Read more →

Amylyx Pharmaceuticals files new drug submission for AMX0035 for the treatment of ALS in Canada

14 June 2021 - Submission supported by data from the CENTAUR trial. ...

Read more →

Controversial Alzheimer’s drug approved in U.S. Where does Canada stand?

10 June 2021 - The Alzheimer Society of Canada welcomed the new treatment urging Canadian health authorities to complete its required ...

Read more →

Health Canada grants interim order authorisation for casirivimab and imdevimab for the treatment of mild to moderate COVID-19

10 June 2021 - Interim data shows treatment with casirivimab and imdevimab resulted in a statistically significant reduction in viral ...

Read more →

Paladin Labs announces approval of Wakix (pitolisant) in Canada

9 June 2021 - Paladin Labs today announced Health Canada's approval of Wakix (pitolisant) for the treatment of excessive daytime sleepiness ...

Read more →

Moderna files for authorisation with Health Canada for its COVID-19 vaccine in adolescents

7 June 2021 - Submission based on Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18 ...

Read more →

Health Canada approves AbbVie's Rinvoq (upadacitinib) for the treatment of adults with active psoriatic arthritis

7 June 2021 - Approval supported by efficacy and safety data of two pivotal Phase 3 trials in which Rinvoq demonstrated ...

Read more →

After repeated losses in the U.S., Catalyst wins a victory in Canada over a rare disease drug

3 June 2021 - In an unexpected move, Canada’s Federal Court quashed the approval of a rare disease drug after ...

Read more →

Put Canadians first by suspending the implementation of harmful drug pricing regulations

4 June 2021 - Innovative Medicines Canada calls on the federal government to suspend the implementation of the Patented Medicines ...

Read more →

Quebec extends public reimbursement of Dupixent (dupilumab) for the treatment of moderate to severe atopic dermatitis to include adolescents

1 June 2021 - Public reimbursement under the Régie de l'assurance maladie du Québec will now apply for Canadians aged ...

Read more →

Health Canada accepts new drug submission for Reduvo as a treatment for patients with chemotherapy-induced nausea and vomiting

2 June 2021 - Tetra Bio-Pharma announced today that Health Canada has accepted its new drug submission for Reduvo and has ...

Read more →

Health Canada approves Opdivo (nivolumab) plus Yervoy (ipilimumab) as the first and only immunotherapy treatment for previously untreated unresectable malignant pleural mesothelioma

2 June 2021 - First new systemic therapy in more than 15 years for cancer related to asbestos exposure. ...

Read more →

Health Canada approves Abecma (idecabtagene vicleucel), the first and only anti-BCMA CAR T cell therapy for relapsed and refractory multiple myeloma

31 May 2021 - Abecma is the first personalised cell therapy available to Canadian patients for the treatment of adults ...

Read more →